GENERAL ATLANTIC, L.P. Q4 2023 Filing
Filed February 13, 2024
Portfolio Value
$7.0B
Holdings
26
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ESMTUSDENGAGESMART | 90,271,540 | $2.1T | 29656.59% | |
| 2 | DLODLOCAL | 63,906,695 | $1.1T | 16218.44% | |
| 3 | XPXP, INC | 29,617,733 | $772.1B | 11077.14% | |
| 4 | ALHCALIGNMENT HEALTHCARE | 60,993,323 | $525.2B | 7533.91% | |
| 5 | ALKTALKAMI | 18,729,806 | $454.2B | 6515.98% | |
| 6 | —HIRERIGHT | 32,109,898 | $431.9B | 6195.78% | |
| 7 | 8DTSQUARESPACE | 10,611,073 | $350.3B | 5025.04% | |
| 8 | KRTXKARUNA THERAPEUTICS | 986,710 | $312.3B | 4480.35% | |
| 9 | EWCZEUROPEAN WAX CENTER | 13,110,492 | $178.2B | 2556.07% | |
| 10 | PHVSPHARVARIS | 6,156,252 | $172.7B | 2477.33% | |
| 11 | CNTACENTESSA PHARMACEUTICALS | 9,681,818 | $77.1B | 1105.62% | |
| 12 | HCMHUTCHMED | 4,000,000 | $72.4B | 1039.23% | |
| 13 | IMCRIMMUNOCORE | 950,000 | $64.9B | 931.12% | |
| 14 | MBLYMOBILEYE | 1,318,782 | $57.1B | 819.59% | |
| 15 | BLNDBLEND LABS | 19,132,440 | $48.8B | 699.92% | |
| 16 | RPRXROYALTY PHARMA | 1,500,000 | $42.1B | 604.47% | |
| 17 | YOUCLEAR SECURE | 2,028,797 | $41.9B | 601.03% | |
| 18 | AKROAKERO THERAPEUTICS | 1,785,714 | $41.7B | 598.18% | |
| 19 | THRDTHIRD HARMONIC BIO | 2,958,762 | $32.5B | 465.64% | |
| 20 | OPENOPENDOOR | 6,321,519 | $28.3B | 406.29% | |
| 21 | RSKDRISKIFIED | 5,324,998 | $24.9B | 357.52% | |
| 22 | SLRNACELYRIN | 2,889,668 | $21.6B | 309.26% | |
| 23 | FUTUFUTU | 309,255 | $16.9B | 242.37% | |
| 24 | 5ZZ0WISH | 609,616 | $3.6B | 52.04% | |
| 25 | GROVGROVE COLLABORATIVE | 936,020 | $1.7B | 23.77% | |
| 26 | ADAGADAGENE | 264,000 | $509.9M | 7.31% |